A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin ...

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

The April 11 order directs an immediate halt on manufacturing, sale, and distribution of these drugs, citing that they were approved without mandatory safety and efficacy evaluations ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

A study by scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) introduces a more cost-effective, scalable ...

A team of researchers from the University of Wollongong (UOW) have discovered that a unique trio of medications could hold ...